Article

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease

2024-10-14

Abstract excerpt

<title>Abstract</title> <p>Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. However, current treatments are directed at symptoms and lack ability to slow or prevent disease progression. Large-scale genome-wide association studies (GWAS) have identified numerous genomic loci associated with PD, which may guide the development of disease-modifying treatments. We presented a systems...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7e770d7c-d68e-5524-b042-d50862ef08d4
DOI: 10.21203/rs.3.rs-4869009/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s diseaseDOI 10.21203/rs.3.rs-4869009/v1Read

Identifying the genetic links between Parkinson’s disease and non-motor symptoms: novel insights into disease mechanismsSemantic proximity Read

Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral SclerosisSemantic proximity Read

Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral SclerosisSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read

Large-scale pathway-specific polygenic risk, transcriptomic community networks and functional inferences in Parkinson diseaseSemantic proximity Read

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity Read

Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study.Semantic proximity Read

Repositioning drugs by targeting network modules: a Parkinson's disease case study.Semantic proximity Read

Integrating dorsolateral prefrontal cortex multi-omics and GWAS summary data reveals genetic etiology of Parkinson’s diseaseSemantic proximity Read

Expanding causal genes for Parkinson’s disease via multi-omics analysisSemantic proximity Read

Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskSemantic proximity Read

Genetic networks in Parkinson’s and Alzheimer’s diseaseSemantic proximity Read